Liver repopulation by transplanted hepatocytes and risk of hepatocellular carcinoma

Transplantation

Volumn 82, Issue 10, 2006, Pages 1319-1323

  Laconi, Sergio ^a   Montisci, Stefania ^a   Doratiotto, Silvia ^a   Greco, Marianna ^a   Pasciu, Daniela ^a   Pillai, Sara ^a   Pani, Paolo ^a   Laconi, Ezio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Cancer risk; Hepatocyte transplantation; Liver repopulation

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; RETRORSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FATE; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; DONOR; FOLLOW UP; HEPATOCYTE TRANSPLANTATION; LIFESPAN; LIVER CELL CARCINOMA; LIVER FUNCTION; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; POSTOPERATIVE PERIOD; PRECANCER; PRIORITY JOURNAL; RAT; RECIPIENT; SURGICAL RISK;

ANIMALS; ANTIGENS, CD26; CARCINOMA, HEPATOCELLULAR; DISEASE MODELS, ANIMAL; HEPATOCYTES; LIVER; LIVER FUNCTION TESTS; LIVER NEOPLASMS; RATS;

EID: 33751253726     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000228239.78290.13     Document Type: Article

References (29)

1. Lake JR. Hepatocyte transplantation. N Engl J Med 1998; 338: 1464.
2. Fox IJ, Roy-Chowdhury J. Hepatocyte transplantation. J Hepatol 2004; 40: 878.
3. Matas AJ, Sutherland DE, Steffes MW, et al. Hepatocellular transplantation for metabolic deficiencies: decrease of plasma bilirubin in Gunn rats. Science 1976; 192: 892.
4. Groth CG, Arborgh B, Bjorken C, et al. Correction of hyperbilirubinemia in the glucuronyl-transferase deficient rat by intraportal hepatocyte transplantation. Transplant Proc 1976; 9: 313.
5. Grossman M, Raper SE, Kozarsky K, et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet 1994; 4: 335.
6. Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998; 338: 1422.
7. Muraca M, Gerunda G, Neri D, et al. Hepatocyte transplantation as a treatment of glycogen storage disease type 1a. Lancet 2002; 359: 317.
8. Grompe M, Laconi E, Shafritz DA. Principles of therapeutic liver repopulation. Semin Liver Dis 1999; 19: 7.
9. Laconi S, Laconi E. Principles of hepatocyte transplantation. Semin Cell Dev Biol 2002; 13: 433.
10. Sandgren EP, Palmiter RD, Heckel JL, et al. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 1991; 66: 245.
11. Rhim JA, Sandgren EP, Degen JL, et al. Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994; 263: 1149.
12. Overturf K, Al-Dhalimy M, Tanguay R, et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tryosinaemia type I. Nature Genet 1996; 12: 266.
13. Kvittingen EA, Rootwelt H, Berger R, Brandtzaeg P. Self-induced correction of the genetic defect of tyrosinemia type I. J Clin Invest 1994; 94: 1657.
14. De Vree JML, Ottenhoff R, Bosma PJ, et al. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 2000; 119: 1720.
15. Mignon A, Guidotti J-E, Mitchell C, et al. Selective repopulation of a normal mouse liver by Fas/CD95-resistant hepatocytes. Nat Med 1998; 4: 1185.
16. Mitchell C, Mallet VO, Guidotti J-E, et al. Liver repopulation by Bcl-x(L) transgenic hepatocytes. Am J Pathol 2002; 160: 31.
17. Guidotti J-E, Mallet VO, Mitchell C, et al. Selection of in vivo retrovirally transduced hepatocytes leads to efficient and predictable mouse liver repopulation. FASEB J 2001; 15: 1849.
18. Kip1 enhances the transplantation efficiency of hepatocytes transferred into diseased livers. J Clin Invest 2001; 108: 383.
19. Laconi E, Sarma DSR, Pani P. Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis 1995; 16: 139.
20. Laconi E, Oren R, Mukhopadhyay DK, et al. Long term, near total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol 1998; 158: 319.
21. Guha C, Sharma A, Gupta S, et al. Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res 1999; 59: 5871.
22. Malhi H, Gorla GR, Irani AN, et al. Cell transplantation after oxidative hepatic preconditioning with radiation alone and ischemia-reperfusion leads to extensive liver repopulation. Proc Natl Acad Sci USA 2002; 99: 13114.
23. Overturf K, Al-Dhalimy M, Ou C-N, et al. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes Am J. Pathol 1997; 151: 1273.
24. Laconi S, Pillai S, Porcu PP, et al. Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol 2001; 158: 771.
25. Thompson NL, Hixson DC, Callanan H, et al. Fischer rat substrain deficient in dipeptidyl peptidase IV activity makes normal steady-state RNA level and an altered protein: use as a liver-cell transplantation model. Biochem J 1991; 273: 497.
26. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13: 29.
27. Satoh K, Kitahara A, Soma Y, et al. Purification, induction and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci USA 1985; 82: 3964.
28. Schoental RJ, Magee PN. Further observations on the subacute and chronic liver changes in rats after a single dose of various pyrrolizidine (senecio) alkaloids. J Pathol Bacteriol 1959; 78: 471.
29. Popp JA, Scortichini BH, Garvey LK. Quantitative evaluation of hepatic foci of cellular alteration occurring spontaneously in Fischer 344 rats. Fundam Appl Toxicol 1985; 5: 314.